Aclaris Therapeutics, Inc. Employee Count
The employee counts Aclaris Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2022-12-31: Employees (as filed) 105; Filing 2023-02-23; Lease expense per employee $9,647.62.
- 2018-12-31: Employees (as filed) 169; Filing 2019-03-18; Lease expense per employee $5,242.60.
- Available history
- 2018-12-31 to 2022-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2022-12-31 | 105 full-time | 2023-02-23 | $9,647.62 operating |
| 2018-12-31 | 169 full-time | 2019-03-18 | $5,242.60 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |